Frontiers | Characteristics of Kawasaki Disease Before and After the COVID-19 Pandemic in a Large Pediatric Heart Disease Center
Frontiers | Thirty Years of Kawasaki Disease: A Single-Center Study at the University Hospital of Lausanne
Kawasaki disease and coronary involvement – All About Cardiovascular System and Disorders
A retrospective cohort study of major adverse cardiac events in children affected by Kawasaki disease with coronary artery aneurysms in Thailand | PLOS ONE
Kawasaki disease incidence in children and adolescents: an observational study in primary care | British Journal of General Practice
Understanding Kawasaki Disease
Kawasaki Disease May Increase the Risk of Subsequent Cerebrovascular Disease | Stroke
Kawasaki Disease Nursing Care Management: Study Guide
Mortality among Children with Kawasaki Disease in Japan | NEJM
Kawasaki disease: AHA statement and recommendations
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
Frontiers | Antibodies and Immunity During Kawasaki Disease
Kawasaki Disease: Complications and Treatment | American Heart Association
Lightning Learning: Kawasaki Disease — EM3
Kawasaki disease: AHA statement and recommendations
Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease. - Abstract - Europe PMC
Diagnosis and Management of Kawasaki Disease | AAFP
Kawasaki Disease – Pearls and Pitfalls – PaediatricFOAM
Mortality among Children with Kawasaki Disease in Japan | NEJM
A) Worldwide incidence of Kawasaki disease per 100,000 children... | Download Scientific Diagram
Kawasaki disease - Wikipedia
Kawasaki Disease — NUEM Blog
RACGP - Kawasaki disease – the importance of prompt recognition and early referral
